The identification and validation of Auger electron-emitting radiopharmaceuticals targeting telomerase for cancer therapy
<p>Telomerase is expressed in the majority (>85%) of tumours but not in differentiated normal tissue. This enzyme catalyses the elongation of telomeres – a process critical for continued cell proliferation. Telomerase is a potential novel target for molecularly-targeted radiotherapy (mR...
Príomhchruthaitheoir: | Jackson, M |
---|---|
Rannpháirtithe: | Vallis, K |
Formáid: | Tráchtas |
Teanga: | English |
Foilsithe / Cruthaithe: |
2013
|
Ábhair: |
Míreanna comhchosúla
Míreanna comhchosúla
-
Selective targeting of homologous recombination deficiency
de réir: Zimmer, J
Foilsithe / Cruthaithe: (2014) -
Targeting EGFR signalling pathway in triple negative breast cancer
de réir: Albukhari, A
Foilsithe / Cruthaithe: (2014) -
Targeting EGFR signalling pathway in triple negative breast cancer
de réir: Albukhari, A
Foilsithe / Cruthaithe: (2014) -
Development of models and methods to assess the efficacy of anti-cancer drugs targeted to the mitochondria
de réir: Potter, M
Foilsithe / Cruthaithe: (2014) -
Radiopharmaceutical Validation for Clinical Use
de réir: Charles A. Kunos, et al.
Foilsithe / Cruthaithe: (2021-03-01)